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a  b  s  t  r  a  c  t
Gas  chromatography  with  mass  spectrometric  detection  (GC–MS)  coupled  with  solid  phase  micro-
extraction  as  pre-concentration  method  (SPME)  was  applied  to identify  and  quantify  volatile  organic
compounds  (VOCs)  emitted  by  human  skin.  A  total  of 64 C4-C10  compounds  were  quantiﬁed  in  skin
emanation  of  31  healthy  volunteers.  Amongst  them  aldehydes  and  hydrocarbons  were  the  predominant
chemical  families  with  eighteen  and  seventeen  species,  respectively.  Apart  from  these,  there  were  eight
ketones,  six heterocyclic  compounds,  six terpenes,  four  esters,  two  alcohols,  two  volatile  sulphur  com-
pounds,  and  one  nitrile.  The observed  median  emission  rates  ranged  from  0.55  to 4790  fmol  cm−2 min−1.uman odor
ntrapped victims
mission rate
PME-GCMS
Within  this  set  of  analytes  three  volatiles;  acetone,  6-methyl-5-hepten-2-one,  and  acetaldehyde  exhib-
ited  especially  high  emission  rates  exceeding  100  fmol  cm−2 min−1. Thirty-three  volatiles  were  highly
present  in  skin  emanation  with  incidence  rates  over  80%.  These  species  can  be  considered  as  potential
markers  of human  presence,  which  could  be  used  for early  location  of entrapped  victims  during  Urban
Search  and  Rescue  Operations  (USaR).
© 2014  The  Authors.  Published  by  Elsevier  B.V. This  is  an  open  access  article  under  the  CC  BY-NC-ND. Introduction
The human body emits hundreds of volatile organic compounds
VOCs) offering unique insight into biochemical processes ongoing
n healthy and diseased human organism [1–4]. In the medical con-
ext, they can be considered as a non-invasive biochemical probe
apable of diagnosing disease processes and monitoring therapy.
or instance, over the last years a robust correlation has been estab-
ished between proﬁles of breath volatiles and lung cancer [5–8],
xidative stress [9,10], or organ rejection after transplantation [11].
hus, the VOC pattern directly relates to the physiological status
f an individual. However, the main obstacle limiting the applica-
ion of this chemical ﬁngerprint within a diagnostic context is the
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570-0232/© 2014 The Authors. Published by Elsevier B.V. This is an open access article unlicense (http://creativecommons.org/licenses/by-nc-nd/3.0/).
insufﬁcient understanding of the origin and metabolic fate of its
constituents.
A human-speciﬁc VOC signature also opens up new prospects
for Urban Search and Rescue operations (USaR) organized after
natural, or man-made disasters (e.g., earthquakes, tropical storms,
explosions, or terrorist attacks). In urban areas such events may
entail building collapses and, thereby, entrapment of people under
ruins. Although USaR teams increasingly rely on specialized techni-
cal equipment supporting the rapid detection of trapped humans,
canines are still the preferred choice [12]. Sniffer dogs can rapidly
scan ruins and track human scent. However, their abilities are
limited. They become tired after approximately 30 min  of inten-
sive search and may  easily get stressed or frustrated once they
are unsuccessful [13]. Consequently, there is a need for sensi-
tive human scent detectors, which could support or even replace
searching dogs. A number of recent studies suggest that chemical
analysis of debris air aiming at constituents of human scent could
meet this demand and considerably improve the effectiveness of
USaR operations [14–20].
Skin, next to breath, is a principal source of human scent
constituents. Contrary to some incidental and temporal sources
like blood or urine, it offers a long-lasting emission of VOCs.
der the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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he composition of skin emanation in humans has received
 broad attention [21]. Numerous studies employing a num-
er of analytical techniques such as Gas Chromatography–Mass
pectrometry (GC–MS) [22–31], High Performance Liquid Chro-
atography (HPLC) [32], Ion Mobility Spectrometry (IMS) [33],
roton Transfer Reaction Mass Spectrometry (PTR-MS) [34–36], or
elected Ion Flow Tube-Mass Spectrometry (SIFT-MS) [37] aimed
t the identiﬁcation of constituents forming the human scent.
owever, GC–MS with solid phase microextracxtion (SPME) as
he pre-concentration method seems to be a gold standard in
his context [20,25,26,30,31,38–40]. This is due to the simplicity
f SPME, its ease of operation, its potential for automation and
he small amounts of sample required to perform extraction. Up
o now more than 400 volatiles belonging to numerous chemi-
al classes have been reported in the literature to be emitted by
uman skin [21]. However, the overwhelming majority of stud-
es present only qualitative data (e.g. occurrence) based frequently
n tentative identiﬁcation [20,22–31,39]. The emission rate/ﬂux
quantitative data) has been determined only for a limited num-
er of species [32,41]. Moreover, most of the studies were focused
n indirect analyses of skin emanation (e.g., species adsorbed on
ifferent materials rubbed on human skin) [20,23,24,26,27,31],
hereby inducing high losses of very volatile compounds during
ampling.
The primary goal of this work was the quantiﬁcation of a wide
ange of reliably identiﬁed VOCs emitted by skin of healthy vol-
nteers in order to ﬁll the literature gap with respect to emission
ates (ﬂux) of skin-borne volatiles. A particular focus has been on
ighly volatile analytes, which cannot properly be detected using
ndirect sampling. Another main objective was the selection of
pecies showing high potential as markers of human presence to
e used during USaR operations. Within this study all volatiles of
nterest were quantiﬁed on the basis of SPME-GC–MS as the pre-
oncentration method.
. Materials and methods
.1. Calibration mixtures
Since the preparation of gaseous calibration mixtures was
escribed in detail in our recent article [18] only a brief outline
f the procedure will be presented here. Gaseous multi-compound
alibration mixtures were prepared from pure liquid or gaseous
ubstances. The reference substances with purities ranging from
0 to 99% were purchased from Sigma–Aldrich (Austria), Fluka
Switzerland), ChemSampCo (USA), Acros Organic (Belgium), and
AFC (USA).
Gaseous mixtures of less volatile species were produced by
eans of a GasLab calibration mixtures generator (Breitfuss
esstechnik, Germany). The generator supports the preparation of
as mixtures at pre-deﬁned humidity levels from pure liquid sub-
tances containing 10 ppb to 100 ppm of each solute. For the aim
f this study, pure substances were additionally diluted at ratios
f 1:2000 to 1:3000 to reduce the resulting concentration levels.
as mixtures exhibiting 90% relative humidity at 25 ◦C with ana-
yte volume fractions ranging from approximately 0.05 to 1000 ppb
ere used during calibration and validation. Alternatively, in case
f highly volatile compounds (e.g., hydrocarbons) multi-compound
aseous standards were prepared by injecting and evaporating a
ew microliters of liquid or gaseous analyte into evacuated 1-L
lass bulbs (Supelco, Canada). The desired calibration levels were
chieved by transferring appropriate volumes of the bulb standard
nto Tedlar bags (SKC Inc., USA) ﬁlled with predeﬁned amounts of
umidiﬁed zero air (90% RH at 25 ◦C as above), the latter being pro-
uced by the GasLab generator. Calibration curves were obtainedgr. B 959 (2014) 62–70 63
on the basis of 3-fold analyses of 6 distinct and independent con-
centration levels.
2.2. Human subjects and sampling.
A cohort of 31 healthy volunteers (16 males, 15 females, age
range 23–55 years, median 35 years, 4 smokers) was recruited. All
subjects gave written informed consent to participate and com-
pleted a questionnaire describing their health and smoking status,
as well as recent food intake. The sample collection was approved
by the Ethics Commission of the Innsbruck Medical University. No
special dietary regimes were applied.
Skin emission measurements followed a modiﬁed version of the
procedure applied by Turner et al. [37]. Hand and forearm were
selected for skin emission analyses as this part of the body can
most easily be accessed during the applied sampling protocol and
thus is the most convenient option for volunteers. Volatiles emit-
ted by human skin were collected into in-house made disposable
Nalophan bags (Kalle Nalo GmbH, Germany). The Nalophan tube
(ﬁlm thickness 20 m,  diameter 165 mm)  was  cut into 45–50 cm
long pieces. Next, a polypropylene valve (SKC Inc.) equipped with a
rubber septum was installed on each Nalophan piece and the open
ends of the tube were sealed with Polyamide (PA) closures (WeLoc,
Sweden) to form a bag. In order to desorb potential contaminants all
bags were pre-conditioned. For this purpose, they were ﬂushed ﬁve
times with high-purity nitrogen (99.9999%), ﬁlled with nitrogen
and heated for approximately 12 h in an oven at 50 ◦C and ﬁnally
ﬂushed again ﬁve times with nitrogen [42].
Prior to each experiment involving a human subject, a blank
experiment was  performed. The pre-conditioned Nalophan bag
was ﬁlled with 2.5 L of high-purity nitrogen and stored at room
temperature for 30 min  (exposed to daylight). Next, the bag content
was analyzed to identify possible bag contaminants, which could
affect the underlying skin emission proﬁles.
Directly before the main experiment the volunteers were asked
to wash their arm thoroughly exclusively with tap water and dry
it with a paper towel. Next, one of the bag closures was  removed
and the volunteer was asked to place his/her arm into the bag. The
bag was  then sealed around the forearm using an elastic strap and
tape. The residual room air ﬁlling the bag was afterwards evacuated
using a membrane pump and 2.5 L of puriﬁed air (GasLab cali-
bration mixtures generator, Breitfuss Messtechnik, Germany) were
introduced into the bag via the polypropylene valve using an EL-
FLOW F201CV digital mass ﬂow controller (Bronkhorst high-tech
B.V., Netherlands). The introduction of high purity air considerably
reduced the VOCs background levels and improved the detection of
species under study. After 30 min  of skin VOCs accumulation a vol-
ume  of 50 mL  was drawn from the bag using a heated (40 ◦C) 50 mL
glass syringe (Roth, Germany). During each experiment additional
room air samples were taken to monitor VOCs levels in ambient
air and measurements of bag and room air temperatures were per-
formed. Finally, the basic dimensions of the part of the volunteer’s
forearm located in the bag were measured to approximately calcu-
late the skin surface involved.
2.3. SPME extraction and chromatographic analysis
The skin emission samples for the SPME-GC–MS analysis were
prepared using a 50 mL  gas-tight glass syringe (Roth, Germany)
equipped with a replaceable needle. Using the latter, a volume of
50 mL  was  drawn from the sampling bag and injected into an evacu-
ated SPME vial (55 mL  nominal volume, Macherey-Nagel, Germany)
sealed with a 1.3 mm  butyl/PTFE septum (Macherey-Nagel,
Germany). The SPME procedure was  carried out automatically
using a multipurpose sampler MPS  (Gerstel, Germany). SPME was
achieved by inserting a 75 m carboxen-polydimethylsiloxane
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CAR-PDMS) ﬁber (Supelco, Canada) into the vial and exposing it
o its content for 25 min  at 20 ◦C. Immediately after extraction the
ber was introduced into the inlet of the gas chromatograph where
he pre-concentrated VOCs were thermally desorbed at 290 ◦C. The
ber was conditioned at 290 ◦C for 5 min  prior to each extraction.
GC–MS analyses were performed using an Agilent 7890A/5975C
ystem (Agilent, USA). During desorption the split/splitless inlet
perated in the splitless mode (1 min), followed by a split mode
t the ratio of 1–35. The volatiles of interest were separated
sing a PoraBond Q column (25 m × 0.32 mm,  ﬁlm thickness 5 m,
tyrene-divinylbenzene copolymer phase, Varian, USA) working in
 constant ﬂow of helium at 1.4 mL/min. The column temperature
rogram was as follows: 40 ◦C for 2 min, increase to 260 ◦C at a rate
f 7 ◦C/min, constant temperature of 260 ◦C for 7 min. The mass
pectrometer worked in a SCAN mode with an associated m/z  range
et from 20 to 200. The quadrupole, ion source, and transfer line
emperatures were kept at 150 ◦C, 230 ◦C, and 280 ◦C, respectively.
The identiﬁcation of compounds was performed in two steps.
irst, the peak spectrum was checked against the NIST mass spectral
ibrary. Next, the NIST identiﬁcation was conﬁrmed by compar-
ng the retention times of peaks of interest with retention times
btained for standard mixtures prepared from pure compounds.
eak integration was based on extracted ion chromatograms. The
pplied quantiﬁer ions are presented in Table 1.
. Results and discussion
.1. Validation parameters
The calculated validation parameters are presented in Table 1.
imits of detection (LODs) were calculated using the algorithm pre-
ented by Huber [43]. More speciﬁcally, standard deviation of 9
onsecutive blank signals and 1% probability (1 − ˛) for the type 1
rror resulting in the coverage factor of 3.05 were used for these
urposes. The LOD values ranged from 0.009 ppb for isoprene to
9 ppb for ethanol. The limit of quantiﬁcation (LOQ) was  deﬁned as
 × LOD. Relative standard deviations (RSDs) were calculated on the
asis of consecutive analyses of ﬁve independent standard mixtures
xhibiting concentrations close to the medians of the observed
evels in real samples. The RSDs fall within the range of 0.5–12%
nd were recognized as satisfactory for the goals of this study. The
nstrument response was found to be linear within the investigated
oncentration ranges, with coefﬁcients of variation ranging from
.942 to 0.999. The LODs of emission rates were estimated using
he average skin surface involved. It must be stressed here that
hese values should be treated as approximate, as in the applied
xperimental setup forearm skin area was not ﬁxed and differed
mongst volunteers.
.2. Human skin proﬁle of VOCs
Overall 64 compounds emitted by human skin were reliably
dentiﬁed and quantiﬁed. Their associated detection and quantiﬁ-
ation incidences as well as the observed concentration ranges
n Nalophan bags are given in Table 2. The presented concen-
ration levels are diminished (if applicable) by the respective
alues obtained for the associated blank samples. Several com-
ounds appearing in very high and variable levels in room air
efore and during experiments (e.g., methanol, methyl acetate,
-methyl-butane, 2-methyl-1-propene, hexane, toluene, benzene)
ere excluded from the following discussion as it was assumed thatheir possible skin emissions would be too distorted by contamina-
ion to allow for a sound analysis. The obtained bag concentration
evels of VOCs together with the dimensions of a volunteer’s fore-
rm skin involved into experiments were used to calculate thegr. B 959 (2014) 62–70
emission rates of VOCs under study. Since the origin and emis-
sion type of species stemming from human skin is in many cases
ambiguous a constant emission was  assumed for these calcula-
tions. The obtained values expressed in femtomols emitted by one
square cm of skin within 1 min  of experiment (fmol cm−2 min−1)
are presented in Table 2.
Ten compounds were omnipresent and further nine were found
in all samples but one. The predominant chemical classes were
aldehydes and hydrocarbons with eighteen and seventeen species,
respectively. Apart from these, there were eight ketones, six het-
erocyclic compounds, six terpenes, four esters, two  alcohols, two
volatile sulphur compounds (VSCs), and one nitrile. 33 species were
found in more than 80% of samples. This group can be considered
as particularly interesting for safety applications.
Aldehydes comprised 28% of all quantiﬁed species. Eight of
them were n-alkanals (C2–C9), four branched-alkanals, and ﬁve
alkenals. Aromatic aldehydes were represented only by benzalde-
hyde. Decanal was also found in all skin samples; however, it was
not quantiﬁed due to dissatisfactory validation parameters. Alde-
hydes exhibited relatively high incidence rates. Only 4 species
from this class were present in less than 70% of samples. The
highest concentrations and thereby emission rates were noted for
acetaldehyde, benzaldehyde, and n-nonanal (see Table 2). Within
this group acetaldehyde showed particularly high emission rates
spread around the value of 244 fmol cm−2 min−1. This acetaldehyde
ﬂux is three-fold smaller than the one provided by Sekine et al. [32]
for human forearm skin (0–6400, median 756 fmol cm−2 min−1).
This discrepancy can stem from the differences in diet regimes
between populations, or different intensities of reactive oxy-
gen species inducing the acetaldehyde production in the sebum
[44–46].
A total number of seventeen hydrocarbons (HC) were found to
be emitted by human-skin. They were predominantly (75%) unsat-
urated (alkenes or dienes). The remaining ones were n-alkanes.
Three HCs (1-heptene, n-heptane and n-octane) were omnipresent
and further seven were detected in more than 80% of the sam-
ples. The concentration levels of the observed hydrocarbons were
lower than the ones noted for aldehydes and did not exceed val-
ues of several ppb. A number of hydrocarbons reported within this
study have not yet been reported in the literature (see Table 2).
This may  result from insufﬁcient identiﬁcation mechanisms (e.g.,
based solely on the NIST mass spectral library check), high volatil-
ity of HCs inducing losses during sampling and indirect analysis, or
both.
A number of ketones were detected in the skin head-space.
Acetone was  deﬁnitely the most abundant compound amongst
the species quantiﬁed within this study. Its levels in bags fell
within the range of 86–808 ppb (median 206 ppb), which agrees
reasonably well with values observed by Turner et al. [37]
for a similar experimental setup. This compound was reported
to be released from human skin by numerous investigators
[23,26,28,32,37]. The emission rates of acetone obtained within
this study (493–3680 fmol cm−2 min−1, median 1100) agree rea-
sonably well with the ones reported by Sekine et al. [32]
(<140–1800 fmol cm−2 min−1, mean 490). However, it should be
mentioned here that Sekine et al. were able to detect acetone in
skin emission of only 37% of volunteers (n = 60), which presumably
stems from the fact that acetone LOD was about 200 times higher
in Sekine’s study (137 fmol cm−2 min−1). Again, some differences
in acetone emission can derive from fasting condition, or different
exposure to factors inducing oxidative stress on the skin surface
and thereby acetone production (UV-radiation, or O3) [28,36]. The
emission rates and incidence of the next frequently observed skin-
borne ketone, 6-methyl-5-hepten-2-one, were also high and spread
around the median value of 133 fmol cm−2 min−1. With the excep-
tion of 2-butanone the remaining species from this family were
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Table  1
Retention times Rt [min], quantiﬁer ions, LODs [ppb], RSDs (%), coefﬁcients of variation (R2), linear ranges [ppb] and average ﬂux LODs [fmol cm−2 min−1] of compounds
under study for skin emission measurements. Compounds are ordered with respect to increasing retention time.
VOC CAS Rt [min] Quantiﬁer ion LOD [ppb] RSD [%] R2 linear range [ppb] Average ﬂux LOD
[fmol × cm−2 × min−1]
Propene 115-07-1 5.84 41 0.59 3.5 0.998 1.76–15.5 3.15
Acetaldehyde 75-07-0 8.08 44 6 8 0.997 18–760 32.1
Ethanol 64-17-5 11.01 45 29 5 0.999 86–1520 155
Acetonitrile 1975-05-08 11.46 41 0.14 5.5 0.999 0.42–100 0.75
2-Butene, (E)- 624-64-6 11.69 56 0.017 2 0.998 0.05–4.6 0.09
2-Butene, (Z)- 590-18-1 11.94 56 0.014 4.2 0.998 0.04–1.8 0.07
2-Propenal 107-02-8 12.90 56 0.11 4.5 0.999 0.33–40 0.59
n-Propanal 123-38-6 13.56 58 0.124 2.4 0.999 0.37–26 0.66
Acetone 67-64-1 13.76 58 0.125 3.5 0.999 0.38–766 0.67
2-Propanol 67-63-0 14.16 45 14.7 8 0.988 44–150 78.6
Dimethyl sulﬁde 75-18-3 14.37 62 0.045 6 0.999 0.13–11 0.24
1-Pentene 109-67-1 16.03 55 0.035 2 0.999 0.1–7.2 0.19
Isoprene 78-79-5 16.15 67 0.009 2.7 0.999 0.03–5.3 0.05
n-Pentane 109-66-0 16.62 43 0.05 1.7 0.998 0.15–5 0.27
1,3-Dioxolane 646-06-0 16.80 74 0.69 6.5 0.997 2.1–21 3.69
2-Propenal, 2-methyl- 78-85-3 17.04 70 0.025 3.4 0.993 0.08–11 0.13
Propanal, 2-methyl- 78-84-2 17.34 72 0.127 5 0.999 0.38–20.5 0.68
3-Buten-2-one 78-94-4 17.64 55 0.086 1.8 0.998 0.26–19 0.46
Furan, 2-methyl- 534-22-5 18.13 82 0.015 1.6 0.999 0.04–9 0.08
n-Butanal 123-72-8 18.16 72 0.2 3.3 0.999 0.6–45 1.07
2-Butanone 78-93-3 18.25 72 0.08 7 0.998 0.17–14 0.43
Furan, 3-methyl- 930-27-8 18.42 82 0.015 2 0.997 0.04–8 0.08
Ethyl  Acetate 141-78-6 19.01 43 0.016 5 0.992 0.05–75 0.09
2-Butenal, (E)- 123-73-9 19.37 70 0.057 3.5 0.996 0.17–11.5 0.30
1,3-Dioxolane, 2-methyl- 497-26-7 19.69 73 0.022 5 0.997 0.07–14 0.12
2-Pentene, 2-methyl- 625-27-4 20.31 69 0.011 1.7 0.999 0.03–12.6 0.06
2-Butene, 2,3-dimethyl- 563-79-1 20.63 69 0.012 5 0.996 0.04–8.3 0.06
1,3-Pentadiene, 2-methyl-, (E)- 926-54-5 20.90 67 0.014 3 0.998 0.04–7.3 0.07
1,3-Pentadiene, 2-methyl-, (Z)- 1118-58-7 21.02 67 0.014 3.5 0.996 0.04–10 0.07
Butanal, 3-methyl- 590-86-3 21.46 44 0.13 5 0.956 0.38–13 0.69
Butanal, 2-methyl- 96-17-3 21.51 57 0.065 4.3 0.999 0.2–18 0.35
Isopropyl acetate 108-21-4 21.69 43 0.025 3 0.995 0.08–50 0.13
2-Pentanone 107-87-9 22.03 43 0.024 7 0.994 0.07–9 0.13
Furan, 2,5-dimethyl- 625-86-5 22.07 96 0.018 0.5 0.999 0.05–6.5 0.10
Sulﬁde, allyl methyl 10152-76-8 22.14 88 0.014 0.9 0.996 0.04–5 0.07
n-Pentanal 110-62-3 22.23 44 0.103 2.2 0.998 0.31–8.5 0.55
2-Butenal, 3-methyl- 107-86-8 23.82 84 0.188 12 0.942 0.6–44 1.00
1-Heptene 592-76-7 23.96 56 0.015 1 0.998 0.05–4 0.08
2-Heptene 592-77-8 24.20 55 0.034 1.5 0.996 0.1–5 0.18
n-Heptane 142-82-5 24.38 71 0.022 1.8 0.996 0.06–6 0.12
Butanal, 2-ethyl- 97-96-1 25.02 72 0.23 11 0.995 0.68–30 1.23
3-Penten-2-one, 4-methyl- 141-79-7 25.39 83 0.23 9 0.983 0.68–41 1.23
Isobutyl acetate 110-19-0 25.55 43 0.07 7 0.988 0.21–14 0.37
2-Hexanone 591-78-6 25.64 58 0.08 5 0.992 0.24–6 0.43
n-Hexanal 66-25-1 25.80 56 0.063 12 0.994 0.19–25 0.34
-Butyrolactone 96-48-0 26.01 42 0.37 8 0.989 1.1–100 1.98
n-Butyl acetate 123-86-4 26.27 56 0.033 11 0.997 0.1–1000 0.18
2-Hexenal, (E)- 6728-26-3 26.68 55 0.25 7 0.985 0.75–5.5 1.34
1-Octene 111-66-0 27.26 55 0.055 1.7 0.994 0.17–7.3 0.29
n-Octane 111-65-9 27.64 43 0.04 3.4 0.991 0.12–6 0.21
2-Heptanone 110-43-0 28.84 58 0.16 10 0.968 0.46–13 0.86
n-Heptanal 111-71-7 29.00 70 0.19 12 0.963 0.57–14 1.02
Benzaldehyde 100-52-7 29.00 106 0.53 10 0.969 1.59–41 2.83
1-Nonene 124-11-8 30.26 56 0.055 2.7 0.985 0.17–6 0.29
n-Nonane 111-84-2 30.58 57 0.1 1.4 0.986 0.29–8 0.53
5-Hepten-2-one, 6-methyl- 110-93-0 31.20 108 0.15 9 0.958 0.43–210 0.80
Furan, 2-pentyl- 3777-69-3 31.62 81 0.026 1.3 0.995 0.08–8 0.14
-Pinene 127-91-3 31.90 93 0.085 4 0.999 0.25–10.5 0.45
n-Octanal 124-13-0 31.92 43 0.3 12 0.981 0.9–30 1.60
p-Cymene 99-87-6 32.72 119 0.1 1.4 0.995 0.3–12.5 0.53
DL-Limonene 5989-27-5 32.94 68 0.125 1.6 0.993 0.38–54 0.67
0
0
0
c
(
3
t
t
2Styrene, p,-dimethyl- 1195-32-0 33.49 117 
Eucalyptol 470-82-6 33.50 81 
n-Nonanal 124-19-6 34.73 57 
haracterized by much lower abundances; however, two  of them
2-pentanone and 3-buten-2-one) exhibited high occurrence.
Amongst heterocyclic compounds only three (2-methyl furan,
-methyl furan, and 2-pentyl furan) occurred in more than 80% of
he cases. The highest levels were noted for 1,3 dioxolane, however,
his compound was detected only in 30% of samples. Interestingly,
,5-dimethyl furan – a volatile usually associated with smoking.46 3 0.992 1.38–32 2.46
.16 6 0.990 0.47–100 0.86
.6 8 0.977 1.8–50 3.21
[47]was found in 40% of the volunteers. Bearing in mind that only
four smokers were recruited this ﬁnding could provide evidence of
environmental exposure to cigarette smoke.Six terpenes were quantiﬁed in the human skin headspace.
The highest incidence rates were observed for DL-limonene (96%),
p-cymene (93%), and -butyrolactone (74%). Within this group,
-butyrolactone exhibited the highest emission rates ranging from
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Table 2
Detection (nd) and quantiﬁcation (nq) incidences of the compounds under study, together with their concentration ranges in Nalophan bags and calculated emission rates. Compounds are divided into chemical classes and ordered
with  respect to decreasing incidence.
Class VOC Incidence nd(nq) Concentration
range (median)
[ppb]
Emission
rate range (median)
[fmol × cm−2 × min−1]
Reported
also by:
Tentative origin
[%] [–]
Aldehydes Acetaldehyde 100(100) 31(31) 27.8–688 (43) 164–3989 (244) A, B, C, D, O (a) Ethanol metabolism [59]
(b) Oxidative degradation of linolenic acid
[45,46]
2-Propenal 100(100) 31(31) 1.36–7.45 (3.44) 6.37–45 (19.5) (a) Smoking [47]
Butanal, 3-methyl- 100(100) 31(31) 1.19–6.45 (2.45) 6.09–26.9 (13.4)
Butanal, 2-methyl- 100(100) 31(31) 0.92–5.43 (2.47) 5.3–24.8 (14) E
n-Propanal 97(97) 30(30) 0.56–20.8 (2.3) 3.44–112 (12.4) B, C, D, E, F (a) Oxidative degradation of linolenic acid and
oleic acid [45,46]
2-Propenal, 2-methyl- 97(97) 30(30) 1.08–12.3 (3.35) 6.42–55.9 (17.4) (a) OH-initiated degradation of isoprene [60]
Propanal, 2-methyl- 97(97) 30(30) 0.90–4 (2.23) 5.48–17.7 (11.7) E
n-Hexanal 97(97) 30(30) 3.43–32.5 (7.56) 16.8–168 (41.9) F, G, H, N (a) Oxidative degradation of linoleic acid,
palmitoleic acid and vaccenic acid, [24,45,46]
n-Nonanal 94(94) 29(29) 3.26–19.2 (11.4) 18.1–119 (58.9) E, F, G, H, I,
J, K, L, M,  N
(a) Oxidative degradation of oleic acid
[24,45,46]
n-Octanal 87(87) 27(27) 4.29–25.9 (6.17) 22.5–150 (33.1) E, F, G, H, I,
J, K, M
(a) Oxidative degradation of oleic acid [45,46]
n-Heptanal 81(77) 25(24) 2.34–11.2 (4.81) 12–60 (27.6) D, E, F, H, M (a) Oxidative degradation of palmitoleic acid,
vaccenic acid [24]
2-Butenal, (E)- 71(71) 22(22) 0.12–5.48 (0.6) 0.62–30.2 (3.06) D (a) Oxidative degradation of linolenic acid [45]
n-Pentanal 71(71) 22(22) 0.79–3.13 (1.62) 3.74–14.9 (8.59) D, F (a) Oxidative degradation of linoleic acid [46]
Benzaldehyde 71(71) 22(22) 12.7–42.5 (29.1) 62–238 (147) E, I, J, K, M,
N, O
n-Butanal 48(48) 15(15) 0.98–53.8 (2.1) 4.6–311 (12) F (a) Oxidative degradation of linolenic acid [45]
2-Hexenal, (E)- 48(35) 15(11) 0.7–1.72 (1.06) 3.29–9.51 (6.29)
2-Butenal, 3-methyl- 39(39) 12(12) 2.36–15.1 (5.28) 13.5–68.7 (28.3) K
Butanal, 2-ethyl- 6(6) 2(2) 1.37–3.99 (2.68) 6.33–26.6 (16.5)
HCs 1-Heptene 100(100) 31(31) 0.04–0.72 (0.29) 0.17–3.28 (1.79)
n-Heptane 100(100) 31(31) 0.30–1.73 (0.6) 1.41–7.89 (2.94) D, E (a) Oxidative degradation of oleic acid [45]
n-Octane 100(100) 31(31) 0.28–3.66 (1.37) 1.75–16.9 (7.14) E (a) Oxidative degradation of oleic acid [45]
Isoprene 97(97) 30(30) 0.16–3.89 (0.82) 0.99–17.7 (4.6) (a) Endogenous cholesterol synthesis [61,62]
(b) Peroxidation of squalene [54]
(c) Cutaneous synthesis of squalene [63]
n-Nonane 97(97) 30(30) 0.80–8.84 (2.42) 4.84–40.3 (12.1) E, M,  N
1-Octene 94(94) 29(29) 0.18–1.16 (0.51) 0.74–7.76 (2.9) D, H
1-Nonene 90(90) 28(28) 0.07–1.72 (0.67) 0.35–8.1 (3.75)
2-Pentene, 2-methyl- 87(87) 27(27) 0.17–11.8 (1.96) 1.05–54 (9.34) (a) Peroxidation of squalene [54]
1,3-Pentadiene, 2-methyl-,
(Z)-
81(81) 25(25) 0.12–1.66 (0.31) 0.62–8.19 (1.7)
1,3-Pentadiene, 2-methyl-,
(E)-
81(77) 25(24) 0.10–0.93 (0.23) 0.51–4.44 (1.24)
Propene 65(61) 20(19) 1.21–4.96 (2.56) 4.97–29.3 (13.13) (a) Peroxidation of squalene [54]
1-Pentene 48(48) 15(15) 0.26–0.68 (0.35) 1.24–3.81 (2.1)
n-Pentane 39(39) 12(12) 0.49–2.86 (0.99) 2.69–13.1 (5.19) D (a) Oxidative degradation of linoleic acid [45]
2-Butene, (E)- 26(26) 8(8) 0.05–0.9 (0.12) 0.30–4.17 (0.57)
2-Heptene 23(23) 7(7) 0.15–0.35 (0.21) 0.75–2.01 (1.29)
2-Butene, (Z)- 10(10) 3(3) 0.11–0.76 (0.36) 0.52–4.42 (1.93)
2-Butene, 2,3-dimethyl- 6(6) 2(2) 2.98–9.12 (6.05) 13.7–43.1 (28.4)
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Table 2 (Continued)
Class VOC Incidence nd(nq) Concentration
range (median)
[ppb]
Emission
rate range (median)
[fmol × cm−2 × min−1]
Reported
also by:
Tentative origin
[%] [–]
Ketones Acetone 100(100) 31(31) 86–808 (206) 493–3680 (1100) A, D, E, G, J,
L, O
(a) Endogenous decarboxylation of Acetyl–CoA
[50]
(b) Oxidative degradation of squalene [28,55]
2-Butanone 100(100) 31(31) 0.59–3.64 (1.17) 3.7–16.6 (6.4) D, E
2-Pentanone 100(100) 31(31) 0.18–1.66 (0.36) 0.85–7.56 (1.94) E (a) Diet [64]
(b) 2-Pentanol metabolism [65]
5-Hepten-2-one, 6-methyl- 97(97) 30(30) 2.63–167 (24.8) 14–918 (133) E, G,  H, J, K,
L, M,  N
(a) Oxidative degradation of squalene [28,55]
3-Buten-2-one 87(87) 27(27) 0.75–3.23 (1.54) 4.12–19.5 (8.31) (a) OH-initiated degradation of isoprene [60]
3-Penten-2-one, 4-methyl- 10(6) 3(2) 3.81–42.63 (23.3) 20.6–247 (133)
2-Hexanone 6(6) 2(2) 0.34–0.53 (0.43) 1.74–3.55 (2.65) E
2-Heptanone 6(6) 2(2) 1.59–1.66 (1.62) 9.02–10.3 (9.66)
Heterocycles Furan, 3-methyl- 97(97) 30(30) 0.08–0.75 (0.17) 0.44–4.15 (0.9) E (a) OH-initiated degradation of isoprene [60]
(b) Produced by skin microbiota (Penicillium
sp., Aspergillus ﬂavus)  [66]
Furan, 2-pentyl- 94(94) 29(29) 0.23–1.03 (0.36) 1.17–5.42 (1.94) (a) Oxidative degradation of linolenic acid [67]
(b) Produced by skin microbiota (Fusarium sp.
and  Aspergillus ﬂavus)  [68]
Furan, 2-methyl- 87(87) 27(27) 0.13–1.01 (0.33) 0.6–4.6 (1.8) E (a) Smoking [47]
1,3-Dioxolane, 2-methyl- 77(77) 24(24) 0.11–3.15 (0.57) 0.63–16 (3.07)
Furan, 2,5-dimethyl- 39(39) 12(12) 0.07–1.38 (0.09) 0.37–8.28 (0.55) (a) Smoking [47]
1,3-Dioxolane 32(32) 10(10) 2.81–21.85 (18.1) 16.4–124 (99)
Terpenes DL-Limonene 97(90) 30(28) 0.18–60.64 (1.64) 0.88–377 (8.76) I, N (a) Diet (ﬂavoring) [64]
(b) Cosmetics, solvents
p-Cymene 94(52) 29(16) 0.31–2.45 (0.46) 1.43–15.3 (2.68) J (a) Diet [64]
-Butyrolactone 74(74) 23(23) 0.97–18.90 (4.84) 5.65–104.5 (26.6) (a) Produced by skin microbiota (Malassezia)
[69]
-Pinene 13(13) 4(4) 0.28–2.81 (0.7) 1.59–18.8 (4.25) M (a) Perfumes, cosmetics
Styrene,  p,-dimethyl- 10(10) 3(3) 0.76–10.17 (1.38) 4.63–63.2 (8)
Eucalyptol 10(10) 3(3) 1.85–14.24 (2.21) 9.07–86 (10.1) (a) Cosmetics
(b) Diet (beverages, meat) [64]
(c) Insecticide component [70]
Esters Ethyl Acetate 10(10) 3(3) 3.74–81.05 (33.6) 21.7–469 (182) N (a) Cosmetics
Isopropyl acetate 6(6) 2(2) 23.87–43.78 (33.8) 138–237 (187) (a) Cosmetics
Isobutyl acetate 6(6) 2(2) 11.63–15.52 (13.6) 63–90 (76) (a) Cosmetics
n-Butyl acetate 10(10) 3(3) 130.20–1409 (885) 659–8140 (4790) (a) Cosmetics
Alcohols Ethanol 19(10) 6(3) 109–7377(329.2) 683–42773 (2005) A, D (a) Oxidative degradation of linoleic acid [45]
(b) Diet
2-Propanol 6(3) 2(1) 87.6 506 D (a) Disinfectants, cosmetics
Sulphurs Dimethyl sulﬁde 81(77) 25(24) 0.13–1.12 (0.48) 0.60–6.06 (2.52) E (a) Endogenous metabolism of
sulfur-containing amino acids [71]
(b) Bacterial decomposition of
sulfur-containing amino acids acids [71]
Sulﬁde, allyl methyl 19(19) 6(6) 0.06–0.5 (0.36) 0.28–3.13 (1.73) (b) Diet, garlic consumption [72]
Other Acetonitrile 90(90) 28(28) 0.47–89 (1.14) 2.39–407 (6.31) D (a) Smoking [47]
Legend: A – Turner, C., et al.,  Rapid Commun Mass Spectrom, 2008, 22(4), 536; B – Moeskops, B.W., et al.,  Physiol Meas, 2006, 27(11), 1187; C – Steeghs, M.M.L., et al.,  Int. J. Mass Spectrom., 2006, 253, 58; D – Ellin, R.I., et al.,. J.
Chromatogr,  1974, 100(1), 137; E – Bernier, U.R., et al., Anal Chem, 2000, 72(4), 747; F – Luo, X.P., et al., Anal Biochem, 1995, 228(2), 294; G – Wisthaler, A. and C.J. Weschler, Proc Natl Acad Sci U S A, 2010, 107(15), 6568; H – Haze,
S.,  et al.,  J Invest Dermatol, 2001, 116(4), 520; I – Zhang, Z.M., et al.,  J Chromatogr B, 2005, 822(1–2), 244; J – Gallagher, M.,  et al.,  Br J Dermatol, 2008, 159(4), 780; K – Ruzsanyi, V., et al., J Chromatogr B, 2012, 911, 84; L – Fruekilde,
P.,  et al.,  Atmospheric Environment, 1998, 32(11), 1893., M – Curran, A.M., et al., J Chromatogr, 2007, 846, 86, N – Dormont, L., et al., J. Exp. Bol., 2013, 216, 2783, O – Sekine Y., et al., J Chromatogr B, 2007, 859, 201.
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The great majority of species from the remaining classes (e.g.,
sters, alcohols) showed very poor detection incidence, which did
ot exceed 20%. Only two compounds dimethyl sulﬁde and ace-
onitrile were characterized by high incidences of 80% and 90%,
espectively. Nevertheless, their head-space concentrations and
hereby emission rates were rather low (with the exception of ace-
onitrile levels in smokers).
.3. Skin-borne VOCs as markers of human presence
An ideal marker of human presence should be omnipresent,
olatile, relatively non-reactive and continuously emitted at rela-
ively high concentrations in the proximity of an entrapped victim.
nalytical possibilities with respect to the ﬁeld identiﬁcation of
uch a biomarker are also of utmost importance. Thus, its physico-
hemical characteristics should allow for its detection by miniature,
asy-to-use, low-power, fast, however, sensitive instruments (e.g.,
hemical sensor arrays, ion mobility spectrometers).
Following this deﬁnition systemic skin volatiles seem to be the
est candidates as their presence mirrors the physiological pro-
esses ongoing in the living organism. Amongst species from this
tudy acetone shows the highest potential in this context. It is
ormed in the liver during fatty acids oxidation from acetoacetate
ndergoing spontaneous decarboxylation [48–50] and released in
onsiderable amounts not only through skin, but also via breath
18,50,51], and urine [52,53]. Another source of acetone emitted
rom human skin is ROS-induced degradation of squalene, an abun-
ant component of human sebum [28,44,54,55]. Finally, acetone
an already be detected at low ppb levels by some portable sensor-
ased instruments [17,56,57].
The entrapped victim is inherently cut off from the predomi-
ant factors inducing oxidative stress on the skin surface such as
V radiation, or O3. Thus, it can be expected that the production
f UV-induced species will be stopped shortly after entrapment.
onsequently, the applicability of compounds from this group may
e limited to the initial period of rescue operations. On the other
and, some of these species stem from constituents unique for
uman sebum (e.g., squalene, sapienic acid, sebaleic acids) and may0%. Various chemical classes of compounds are indicated by different colors.
therefore be regarded as unique and speciﬁc markers of human
beings. For example, the squalene-related volatile 6-methyl-5-
hepten-2-one is very abundant in human odor [24,26,30,33,38].
Although it was  also found to be emitted by some plants [28] it
could be a biomarker of trapped humans in urban environments.
Nevertheless, the UV-, or bacterial-induced decomposition of these
unique lipids is poorly known and demands additional studies.
Bearing in mind the considerable shortage of information on
the origin of numerous VOCs reported here the only reasonable
criteria for the selection of tentative markers of human pres-
ence are their omnipresence and concentration levels. An emission
pattern of skin-borne volatiles with occurrence greater than 80%
is presented in Fig. 1. Three compounds (acetone, 6-methyl-5-
hepten-2-one, and acetaldehyde) were emitted with particularly
high emission rates exceeding 100 fmol cm−2 min−1. In terms of
chemical class, aldehydes are the most represented and abundant
species in the above subset. The 33 selected species in Fig. 1 cre-
ate an initial library of potential skin-borne markers of human
presence to be veriﬁed during ﬁeld studies. Interestingly, ﬁve com-
pounds from this list (acetone, n-hexanal, DL-limonene, n-octanal
and n-nonanal) have recently been proposed as preliminary human
markers during simulation experiments with entrapped volunteers
involving ion mobility spectrometry [58].
4. Conclusions
The present study aimed at the reliable identiﬁcation and quan-
tiﬁcation of a wide range of VOCs released by human skin. 64
volatiles were quantiﬁed in skin emanations of 31 healthy vol-
unteers. The observed median emission rates ranged over several
orders of magnitude from 0.55 to 4790 fmol cm−2 min−1. The quan-
tiﬁed compounds belong to several chemical classes; however,
aldehydes and hydrocarbons are the most numerous ones. The
observed emission rates agree reasonably well with the available
literature data. It should be stressed that some species may  origi-
nate from several distinct sources and their production is still far
from being completely understood. In particular, the term endoge-
nous as used in this manuscript embraces metabolic species as
well as diet-, and drug-related ones. Moreover, the contribution
of gut bacteria to the generation of endogenous VOCs cannot
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e ignored. 33 volatiles occurred in more than 80% of the sam-
les and these species can be regarded as potential markers of
uman presence. Amongst them acetone, 6-methyl-5-hepten-2-
ne, and acetaldehyde exhibited the highest emission rates. These
ompounds can also be detected by some miniature, easy-to-use,
ow-power analytical instruments such as ion mobility spectrome-
ry (multicapillary column-ion mobility spectrometry (MCC-IMS),
spiration ion mobility spectrometry (AIMS), ﬁeld asymmetric
aveform ion mobility spectrometry (FAIMS)), or sensor boards,
hich appear to be natural candidates for human scent detectors
o be used during USaR operations. Nevertheless, further ﬁeld stud-
es are necessary to conﬁrm their applicability for the fast detection
f entrapped victims.
Several limitation of the study should be indicated. Firstly,
ighly volatile species C3-C10 were targeted. This resulted from
he fact that the compounds characterized by high vapor pres-
ure have a higher potential for being markers of human presence.
ext, only reliably identiﬁed and quantiﬁed volatiles were reported
ithin this study. A number of VOCs could not be identiﬁed and/or
uantiﬁed properly, either due to the unavailability of pure sub-
tances from commercial vendors, or due to problems related to
he preparation of reliable standard mixtures. Consequently, some
nteresting volatile compounds emitted from skin may  not be
ncluded in the context of the present study. Finally, only forehand
kin was involved in the experiments. Due to the differences in the
istribution of sebaceous glands, the composition and thickness of
he sebum vary between different parts of the body [44]. Conse-
uently, the emission of sebum-related VOCs may  be affected by
hese variations [26].
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